Seroprevalence of hepatitis B and C infection markers among children and adolescents in the Southern Brazilian region;Soroprevalência dos marcadores de infecção das hepatites B e C em crianças e adolescentes da região sul do Brasil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 53, Issue 1, 2011, Pages 13-17

  do Livramento, Andréa ^a   de Cordova, Caio Mauricio Mendes ^b   Spada, Celso ^a   Treitinger, Arício ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Adolescents; Hepatitis B; Hepatitis C

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION RATE; MALE; SCHOOL CHILD; SEROPREVALENCE;

ADOLESCENT; BIOLOGICAL MARKERS; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 79953022720     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652011000100003     Document Type: Article

References (45)

1. Al-Faleh FZ, Al-Jeffri M., Ramia S, Al-Rashed R, Arif M, Rezeig M., et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect. 1999;38:167-170.
2. Andrade AFB, Oliveira-Silva M, Silva SGC, Motta IJ, Bonvicino CR. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz. 2006;101:673-676.
3. Antunes H, Macedo M, Estrada A. Taxa de cobertura vacinal com imunização para o vírus da hepatite B. Acta Med Port. 2004;17:303-308.
4. Balogun MA, Laurichesse H, Ramsay ME, Sellwood J, Westmoreland D, Paver WK, et al. Risk factors, clinical features, and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Commun Dis Public Health. 2003;6:34-39.
5. Batista SMF, Andreasi MSA, Borges AMT, Lindenberg AS, Silva, AL, Fernandes TL, et al. Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz. 2006;101:263-267.
6. Beasley RP, Hwang LY. Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins; 1991. p. 532-535.
7. Bonanni P, Pesavento G, Bechini A, Tiscione E, Manelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine. 2003;21:685-691.
8. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm. Rep. 2003;52(RR-1):1-36.
9. Chan CY, Lee SD, Tsai YT, Lo KJ. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol. 1995;10:192-197.
10. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health. 2006;11:1496-502.
11. Dalgard O, Jeansson S, Skaug K, Rakmerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol. 2003:38:864-870.
12. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171-184.
13. El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008;12:495-499.
14. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004:127(5 Suppl 1):S27-34.
15. Ferreira CT, Silveira TR. Hepatites virais: aspectos da epidemiologia e da prevenção. Rev Bras Epidemiol. 2004:7:473-487.
16. Gerner P, Wirth S, Wintermeyer P, Walz A, Jenke A. Prevalence of hepatitis C virus infection in children admitted to an urban hospital. J Infection. 2006;52:305-308.
17. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S. et al. Serological pattern "anti-HBc alone" report on a workshop. J Med Virol. 2000;62:450-455.
18. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology, 1997;26:786-791.
19. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T. et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis. 2006;6:101.
20. Jonas MM, Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr. 1997;131:314-316.
21. Ladehof ML, Bueno EC. Incidência de hepatites virais em Blumenau - SC, Brasil. Acta Farm Bonaerense. 2005;24:436-440.
22. Lang K, Danchenko N, Gondek K, Shah S, Thompson D. The burden of illness associated with hepatocellular carcinoma in the United States. J Hepatol. 2009;50:89-99.
23. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005;34(Suppl 1):S1-53.
24. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187:134-138.
25. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, et al. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine, 2006;24:759-765.
26. Madani TA. Trend in incidence of hepatitis B vírus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Trans R Soc Trop Med Hyg. 2007;101:278-283.
27. Ministério da Saúde. Programa Nacional de Imunizações. Brasília: Secretaria de Vigilância em Saúde; 2003. 208p.
28. Motta VT, Wagner MB. Bioestatística. Caxias do Sul: Educs; 2003. 201p
29. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol. 2008;80:53-57.
30. Odusanya OO, Alufohai FE, Meurice FP, Wellens R, Weil J, Ahonkhai VI. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. Int J Infect Dis. 2005;9:139-143.
31. Pyrsopoulos NT, Reddy KR. Hepatitis B. eMedicine, 2009. Available from: http://emedicine.medscape.com/article/177632-overview. Accessed December 19, 2009.
32. Riestra S, Fernández E, Leiva P, Garcia S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of Northern Spain. Eur J Gastroenterol Hepatol. 2001;13:477-481.
33. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HBsAg, Anti-HBc and Anti-HCV in Southern Brazil, 1999-2001. Braz J Infect Dis. 2003;7:262-267.
34. Sanches GBS, Honer MR, Pontes ERJC, Aguiar JI, Ivo ML. Caracterização soroepidemiológica da infecção pelo vírus da hepatite B em profissionais de saúde da atenção básica no Estado de Mato Grosso do Sul, Brasil. Rev Panam Infectol. 2008;10:17-22.
35. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-567.
36. Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis. 1998;26:895-897.
37. Silva PA, Fiaccadori FS, Borges AMT, Silva SA, Daher RR, Martins RM, et al. Seroprevalence of hepatitis B virus infection and seroconvertion to anti-HBsAg in laboratory staff in Goiânia, Goiás. Rev Soc Bras Med Trop. 2005;38:153-156.
38. Silva RSU, Ribeiro SAL, Silveira RP, Freitas MS. Avaliação da pré-triagem sorológica para o marcador do vírus da hepatite B (anti-HBc total) em candidatos à doação de sangue no Estado do Acre, 2002. Rev Soc Bras Med Trop. 2006;39:179-182.
39. Souto FJD, Fontes CJF, Oliveira SS, Yonamine F, Santos DRL, Gaspar AMC. Prevalência da hepatite B em área rural de município hiperendêmico na Amazônia Mato-grossense: situação epidemiológica. Epidemiol Serv Saúde. 2004;13:93-102.
40. Tang SX, Yu GL. Intrauterine infection with hepatitis B virus. Lancet. 1990;335:302.
41. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect. 2001;43:187-190.
42. Valente VB, Covas DT, Passos ADC. Marcadores sorológicos das hepatites B e C em doadores de sangue do Hemocentro de Ribeirão Preto, SP. Rev Soc Bras Med Trop. 2005;38:488-492.
43. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J Infect Dis. 1997;175:674-677.
44. World Health Organization. Hepatitis C. World Health Organization; 2002. 69p. Available from: http://www.who.int/csr/disease/hepatitis/Hepc.pdf
45. World Health Organization. Hepatitis B. 2008. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed December 15, 2009.